2019 Volume 28 Issue 2 Pages 217-224
Biocompatible scaffolding materials play an important role in bone tissue engineering. This study sought to assess the biocompatibility and osteoinductivity of a chitosan (CS)/collagenI(ColI)/multi-walled carbon nanotube (MWCNT) composite scaffold blended with bone morphogenetic protein-6 (BMP-6) and seeded with bone marrow mesenchymal stem cells (BMMSCs). The composite was fabricated using varying quantities of MWCNT to determine the appropriate combination, and combined with BMP-6 by blending and vacuum freeze-drying. Scanning electron microscopy (SEM) was used to observe the morphology of the CS/ColI/MWCNT (CCM) scaffolds. The porosity and mechanical properties of the composite scaffolds were measured. Scaffolds were seeded with BMMSCs in vitro and analyzed using SEM, CCK-8 assay and alkaline phosphatase (ALP) activity. To assess the in vivo utility of the composite scaffolds, critical-sized calvarial bone defects were prepared in 15 Sprague–Dawley rats and implanted with pre-seeded scaffolds (the CCM scaffold+BMMSCs group and the BMP-6/CCM scaffold+BMMSCs group) or left untreated (control). Three-dimensional computerized tomography and hematoxylin–eosin (HE) staining were used to evaluate bone formation at 8 weeks postoperatively. We found that higher concentrations of MWCNT decreased the porosity of the scaffold but increased its mechanical strength. In vitro, we found that BMP-6/CCM scaffolds provided the best conditions for BMMSCs proliferation and osteogenic differentiation. Similarly, BMP-6/CCM scaffolds seeded with BMMSCs could more effectively induce new bone formation in critical-sized calvarial bone defects compared with the other three groups. The BMP-6/CCM scaffold possesses good biocompatibility and induces bone formation in vitro and in vivo.